FACILITY: Feeding the fAmiLy: the Intergenerational approaCh to fIght obesiTY (FACILITY)

December 11, 2023 updated by: Valeria Calcaterra, Buzzi Children's Hospital

Retrospective Investigation of Lifestyle and Socio-cultural-economic Determinants Driving to Early Adiposity Rebound (FACILITY)

The FACILITY STUDY is aimed at evaluating maternal and children social, cultural, economic and lifestyle-related risk factors for the development of childhood overweight, obesity and early adiposity rebound (EAR). This study consists of two phases: a cross-sectional phase and a retrospective case-control study.

Study Overview

Status

Not yet recruiting

Detailed Description

The FACILITY retrospective case-control study is conducted in one Italian hospital in Milan (Buzzi Children's Hospital) on children and adolescents (2-18 years old) with EAR and their mothers (≥ 18 years old). The estimated duration is 24 months.

The primary objective of the FACILITY retrospective case-control phase is to identify maternal and child lifestyle and health determinants of EAR associated with childhood obesity. The secondary objective is to identify culture-accepted early-tailored-efficiency "model to action" aligned with the Maternal, New-born, and Child Health (MNCH) continuum care approach. This "policy-model" will be based on the results of the retrospective study and on the analysis of the current scientific evidence and on the research of the global, national and local policies (city of Milan).

Participants of this study are mother-child dyads previously enrolled in the FACILITY cross-sectional study and willing to participate in the retrospective phase or newly enrolled patients from the hospital according to the eligible criteria. If eligible, variables related to the mothers and to the children will be retrospectively investigated with structured interviews and/or by consulting medical records.

For the mothers, anthropometric variables (height and weight during and after pregnancy) will be obtained from medical records, if available, or will be requested orally by structured interviews. In addition, pathological anamnesis and drug consumption during pregnancy will be evaluated with the same methodologies. Information related to pregnancy, supplements consumption during pregnancy, as well as dietary, smoking, and alcohol habits during pregnancy and breastfeeding will be assessed with structured interviews.

For the child, the nutritional status during the first 1000 days will be evaluated with the pediatric health booklet (weight, height/length, and head circumference). The type of breastfeeding and weaning characteristics will be investigated through a structured interview with the mothers. The child's dietary habits, physical activity, and motor gross achievement will be explored with the same methodologies.

Study Type

Observational

Enrollment (Estimated)

269

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The retrospective study population will be a subgroup of the population previously enrolled during the cross-sectional study according to the previously identified eligibility criteria, specifically: mother-child dyads with overweight or obesity and early adiposity rebound (case) and mother-child dyads with healthy weight (control) will be enrolled. The control group will be matched to the cases selected on the basis of various factors (e.g., age, sex, race) to ensure to reduce confounding factors. New subjects will be enrolled according to the eligibility criteria of the retrospective study if the simple size is not reached.

Description

Inclusion criteria (CASE GROUP)

For mothers:

  • Age ≥ 18 years old;
  • Admitted to the Department of Pediatrics, Buzzi Children's Hospital, Milan, Italy;
  • Written and signed informed consent.

For the children/adolescent:

  • Age > 2 years and < 18 years old;
  • Early adiposity rebound (< 5 years of age);
  • Overweight (between 2-3 Z-score) and obesity (≥ 3 Z-score) diagnosis according to the CDC growth charts.
  • Admitted to the Department of Pediatrics, Buzzi Children's Hospital, Milan, Italy;
  • Mother and father/legal guardian had written and signed informed consent.

Inclusion criteria (CONTROL GROUP)

For mothers:

  • Age ≥ 18 years old;
  • Admitted to the Department of Pediatrics, Buzzi Children's Hospital, Milan, Italy;
  • Written and signed informed consent.

For the children/adolescent:

  • Age > 2 years and < 18 years old;
  • Early adiposity rebound (< 5 years of age);
  • Admitted to the Department of Pediatrics, Buzzi Children's Hospital, Milan, Italy;
  • Mother and father/legal guardian had written and signed informed consent.

Exclusion criteria (CASE GROUP and CONTROL GROUP)

For the mothers:

  • Mother had not written and signed informed consent;
  • Inability to understand the Italian and English language.

For the children/adolescent:

  • Endocrine disorders (hypothyroidism, hypercortisolism, growth hormone deficiency);
  • Central nervous system damage (hypothalamic-pituitary damage because of surgery or trauma);
  • Genetic diseases either monogenic (leptin deficiency, MC4R mutation) or pleiotropic genetic syndromes (Prader-Willi, Bardet-Biedl);
  • Mother and father/legal guardian had not written and signed informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Case group - Mother-child dyads
Case group: mother-child dyads (including children with overweight or obesity and early adiposity rebound).
Control group - Mother-child dyads
Control group: mother-child dyads (including children with healthy weight).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Early adiposity rebound (EAR)
Time Frame: Day 1
Child health booklet: early adiposity rebound (years) if minimum BMI occurred before 5 years of age.
Day 1
Overweight and obesity
Time Frame: Day 1
BMI percentile in the Center for Disease Control (CDC) growth charts (overweight: 85th-95th percentile/2-3 Z score; obesity ≥ 95th percentile/≥ 3 Z score).
Day 1
Breastfeeding mode
Time Frame: Day 1
Structured interview (exclusive breastfeeding, formula feeding, mixed mode).
Day 1
Mode and characteristics of weaning
Time Frame: Day 1
Structured interview (time of initiation, foods' introduction sequence and proposed portions, introduction or non-introduction of all food categories, difficulties experienced by the mother or the child, safety measures, proper feeding in accordance with appetite and satiety signals, typical food traditions of the maternal culture/ethnicity).
Day 1
Eating habits between 1 and 2 years of age
Time Frame: Day 1
Structured interview (food and beverages consumed at breakfast, lunch, dinner and snacks, meal skipping, dietary variety).
Day 1
Physical activity during the first 2 years
Time Frame: Day 1
Structured interview (minutes and/or hours of daily physical activity). Results will be compared with WHO guidelines.
Day 1
Gross Motor Milestone Development
Time Frame: Day 1
Structured interview (month when child started to walk). If age starting walking will be >18 months of age the child will be categorized as "late Motor Milestone".
Day 1
Socio-demographic status for children
Time Frame: Day 1
Structured interview: child age (year), race/ethnicity (Caucasian, Black, Medioriental, Asiatic, Hispanic), education level (none, elementary, middle school, high school, degree), number of people in the house, number of years in Italy.
Day 1
Gestational weight gain
Time Frame: Day 1
Difference between pre- and post-pregnancy weight (kg). The gestational weight gain will be compared with IOM Pregnancy Weight Guidelines.
Day 1
Pregnancy characteristic
Time Frame: Day 1
Structured interview: spontaneous or assisted pregnancy, pregnancy related-diseases, delivery mode (natural or caesarean), birth spacing (year).
Day 1
Dietary pattern during pregnancy
Time Frame: Day 1
Structured interview (adherence to particular nutritional advice, the person/expert who gave the nutritional information, dietary pattern followed, consumption of typical traditional food/dishes).
Day 1
Supplements consumed during pregnancy
Time Frame: Day 1
Structured interview (number and type of supplement consumed, period of assumption, who advised her to take the supplement).
Day 1
Food knowledge
Time Frame: Day 1
Structured interview (choose between food options to identify foods containing carbohydrates/dietary fiber, foods low in fats, foods richest in protein/calories, individual perception on the definition of a balanced diet and healthy eating, perception of a relationship between dietary pattern and health status).
Day 1
Smoking habits during and after pregnancy
Time Frame: Day 1
Structured interview. Smoking of traditional tobacco cigarettes (manufactured or hand-rolled cigarettes) or electronic cigarettes or heated tobacco product (HTP) products before, during, after pregnancy. Based on smoking declaration women will be categorized as follows: never smoker (i.e., never smoked), past smoker (i.e., current nonsmoker), current smoke (i.e., current user of tobacco or electronic cigarette or HTP products).
Day 1
Alcohol consumption during pregnancy
Time Frame: Day 1
Structured interview. Weekly consumption of alcohol units during and after pregnancy [1 alcohol unit = 12 g = small glass of red/white/rosé wine = can of double malt beer = small shot of hard liquor]; alcohol consumption history. Based on alcohol consumption declaration, women will be categorized as follows: abstainers (i.e., subjects who do not drink alcohol, zero Units of Alcohol (U.A.)), occasional drinkers (i.e., subjects who drink less than 1 U.A./week), and daily drinkers (i.e., subjects who regularly drink alcohol, more than 1 U.A./week).
Day 1
Socio-demographic characteristics status for mothers
Time Frame: Day 1
Structured interview. Mothers' age, marital status, race/ethnicity, nationality, education level, residence, number of people in the house, current job, number of children, number of years in Italy, household status, household income.
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Development of a "Model to action" policy to tackle childhood obesity
Time Frame: Day 1
"policy-model" based on the results of the retrospective study
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Hellas Cena, Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, via Bassi 21, 27100 Pavia, Italy. Clinical nutrition Unit, General Medicine, ICS Maugeri IRCCS, 27100 Pavia, Italy
  • Principal Investigator: Valeria Calcaterra, Pediatric Department, Buzzi Children's Hospital, 20154 Milano, Italy. Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2023

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

November 23, 2023

First Submitted That Met QC Criteria

December 1, 2023

First Posted (Actual)

December 11, 2023

Study Record Updates

Last Update Posted (Actual)

December 18, 2023

Last Update Submitted That Met QC Criteria

December 11, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Subscribe